Drug Pipelines Begin to Fill For Big Pharma

The big U.S. and European drug companies are dealing with a 'cliff' of their own as blockbuster drugs lose their patent protection. But they are turning back to researching and developing new drugs to fill the gap and the industry has been one of the better performing groups in health care so far this year.